The methodology of quantitation of microvessel density and prognostic value of neovascularization associated with long-term survival in Japanese patients with breast cancer

Breast Cancer Research and Treatment

Volumn 53, Issue 1, 1999, Pages 19-31

  Kato, Takao ^a   Kimura, Tsunehito ^a   Ishii, Nobue ^a   Fujii, Akiho ^a   Yamamoto, Kazuko ^a   Kameoka, Shingo ^a   Nishikawa, Toshio ^a   Kasajima, Takeshi ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Breast cancer; Long term survival; Microvessel density; Neovascularization; Quantitation

Indexed keywords

CYCLINE; PROTEIN P53;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BREAST CANCER; CANCER SURVIVAL; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; METHODOLOGY; MULTIVARIATE ANALYSIS; ONCOGENE NEU; PRIORITY JOURNAL; PROGNOSIS; TUMOR VASCULARIZATION;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; FEMALE; FOLLOW-UP STUDIES; HUMANS; JAPAN; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOVASCULARIZATION, PATHOLOGIC; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; RECEPTOR, ERBB-2; SURVIVORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033051490     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006193024382     Document Type: Article

References (38)

1. Weidner N, Semple JP, Welch WR, Folkman J: Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 324: 1-8, 1991
2. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, Meli S, Gasparini G: Tumor angiogenesis: A new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 84: 1875-1887, 1992
3. Gasparini G, Weidner N, Bevilacqua P, Maluta S, Palma PD, Caffo O, Barbareschi M, Boracchi P, Marubini E, Pozza F: Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma. J Clin Oncol 12: 454-466, 1994
4. Simpson JF, Ahn C, Battifora H, Esteban JM: Endothelial area as a prognostic indicator for invasive breast carcinoma. Cancer 77: 2077-2085, 1996
5. Fregene T, Khanuja PS, Gimotty P, Gimotty P, George J, Pienta KJ: Angiogenesis does not predict recurrence in patients with primary breast cancer (abstract). Am Soc Clin Oncol 12: 67, 1993
6. Van Hoef MEHM, Knox WF, Dhesi SS, Howell A, Schor AM: Assessment of tumor vascularity as a prognostic factor in lymph node negative invasive breast cancer. Eur J Cancer 29: 1141-1145, 1993
7. McCaskill-Stevens W, Broshers J: Angiogenesis and survival in breast cancer patients aged thirty five and under (abstract). Proc Am Soc Clin Oncol 14: 124, 1995
8. Goulding H, Rashid NFNA, Robertson JF, Bell JA, Elston CW, Blamey RW, Ellis IO: Assessment of angiogenesis in breast carcinoma: an important factor in prognosis? Hum Pathol 26: 1196-1200, 1995
9. Kato T, Kimura T, Miyakawa R, Tanaka S, Yamamoto K, Kameoka S, Hamano K, Aiba M, Kawakami K: A clinicopathologic study of angiogenesis in Japanese patients with breast cancer. World J Surg 21: 49-56, 1997
10. Stemmermann GN, Catts A, Fukunaga FH, Horie A, Nomura AMY: Breast cancer in women of Japanese and Caucasian ancestry in Hawaii. Cancer 56: 206-209, 1985
11. Wynder EL, Kajitani T, Kuno J, Lucas JC Jr, De Palo A, Farrow J: A comparison of survival rates between American and Japanese patients with breast cancer. Surg Gynecol Obstet 117: 196-200, 1963
12. Bloom HIJ, Richardson WW: Histologic grading and prognosis. Br J Cancer 11: 359-377, 1957
13. Kato T, Kimura T, Miyakawa R, Tanaka S, Kamio T, Yamamoto K, Hamano K, Aiba M, Kawakami M: Clinicopathologic features associated with long-term survival in node-negative breast cancer patients. Surg Today 26: 105-114, 1996
14. Kaplan EL, Meier P: Non parametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481, 1958
15. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50: 163-170, 1966
16. Cox DR: Regression models and life tables. J R Stat Soc B 34: 187-202
17. Weigand RA, Isenberg WM, Russo J, Brennan MJ, Rich MA: Blood vessel invasion and axillary lymph node involvement as prognostic indicators for human breast cancer. Cancer 50: 962-969, 1982
18. Bettelheim R, Mitchell D, Gusterson, BA: Immunocytochemistry in the identification of vascular invasion in breast cancer. J Clin Pathol 37: 364-366, 1984
19. Saigo PE, Rosen PP: The application of immunohistochemical stains to identify endothelial-lined channels in mammary carcinoma. Cancer 59: 51-54, 1987
20. Lee AKC, Delellis RA, Silverman ML, Heatley GJ, Wolfe HJ: Prognostic significance of peritumoral lymphatic and blood vessel invasion in node-negative carcinoma of the breast. J Clin Oncol 8: 1457-1465, 1990
21. Bosari S, Lee AKC, Delellis RA, Wiley BS, Heatley GJ, Silverman ML: Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol 23: 755-761, 1992
22. Horak ER, Leek R, Klenk N, Lejeune S, Smith K, Stuart N, Greenall M, Stepniewska K, Harris A: Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 340: 1120-1124, 1992
23. Aranda FI, Laforga JB: Microvessel quantitation in breast ductal invasive carcinoma correlation with proliferative activity, hormonal receptors and lymph node metastases. Path Res Pract 192: 124-129, 1996
24. Marinho A, Soares R, Ferro J, Lacerda M, Schmitt FC: Angiogenesis in breast cancer is related to age but not to other prognostic parameters. Path Res Pract 193: 267-273, 1997
25. Kohlberger PD, Obermair A, Sliutz G, Heinzl H, Koelbl H, Breitenecker G, Gitsch G, Kainz C: Quantitative immunohistochemistry of factor VIII-related antigen in breast carcinoma. A comparison of computer-assisted image analysis with established counting methods. Am J Pathol 105: 705-710, 1996
26. Liotta LA, Kleinerman J, Saidel G: The significance of hematogenous tumor cell clumps in the metastatic process. Cancer Res 36: 889-894, 1976
27. Liotta LA, Kleinerman J, Saidel G: Quantitative relationships of intravascular tumor cells, tumor vessels and pulmonary metastases following tumor implantation. Cancer Res 34: 997-1004, 1974
28. Dvorak HF, Nagy JA, Dvorak JT, Dvorak AM: Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules. Am J Pathol 133: 95-109, 1988
29. Nagy JA, Brown LF, Senger DR, Lanir N, Van De Water L, Dvorak AM, Dvorak HF: Pathogenesis of tumor stroma generation: a critical role for leaky blood vessels and fibrin deposition. Biochim Biophys Acta 948: 305-326, 1988
30. Takaya O: The report of clinical statistical studies on registered mammary cancer patients in Japan. Japan Mammary Cancer Society 10: 13-21, 1993
31. Haagensen CD: The relation of age to the frequency of breast carcinoma. In: Haagensen CD (ed), Disease of the Breast. 3rd edition. Philadelphia, PA, W.B., Saunders Company, 1986, pp 861
32. May E, Mouriesse H, May-Levin F, Qian JF, Delarue JC: Human breast cancer: Identification of populations with a high risk of early relapse in relation to both estrogen receptor status and c-erbB-2 overexpression. Br J Cancer 62: 430-435, 1990
33. Gasparini G, Gullick WJ, Bevilacqua P, Sainsbury JRC, Salvatore M, Boracchi P, Testolin A, La Malfa G, Pozza F: Human breast cancer: Prognostic significance of the c- crbB-2 oncoprotein compared with epidermal growth factor receptor, DNA ploidy, and conventional pathologic features. J Clin Oncol 10: 686-695, 1992
34. Barnes DM, Lammie GA, Millis RR, Gullick WL, Allen DS, Altman DG: An immunocytochemical evaluation of c- erbB-2 expression in human breast carcinoma. Br J Cancer 58: 448-452, 1988
35. Fisher ER, Gregorio RM, Fisher B: The pathology of invasive breast cancer. A syllabus derived from findings of the National Surgical Adjuvant Breast Project (Protocol No. 4). Cancer 36: 45-49, 1975
36. Carter D, Elkins RC, Pipkin RD, Abbey H, Shepard RH: Relationship of necrosis and tumor border to lymph node metastasis and 10-year survival in carcinoma of the breast. Am J Surg Pathol 2: 39-46, 1978
37. Poller DN, Roberts EC, Bell JA, Elston CW, Blamey RW, Ellis IO: p53 protein expression in mammary ductal carcinoma in situ. Relationship to immunohistochemical expression of estrogen receptor and c-c-rbB-2 protein. Hum Pathol 24: 463-468, 1993
38. Fresno M, Molina R, Perez del Rio MJ, Alvarez S, Diaz- Iglesias, Garcia I, Hererro A: p53 expression is of independent predictive value in lymph node-negative breast carcinoma. Eur J Cancer 33: 1268-1274, 1997